Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cecolin Phase III Efficacy and Safety Study in Healthy Women
NCT01735006Phase 3Completed
- Sponsor
- Xiamen University
- Start
- Nov 2012
- Primary completion
- Aug 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human papillomavirus bivalent (types 16, 18) vaccine in human papillomavirus infection, Cervical Cancer (CC), sponsored by Xiamen University. Started Nov 2012; status: completed.
02
Drugs
recombinant human papillomavirus bivalent (types 16, 18) vaccine
03
Conditions
human papillomavirus infectionCervical Cancer (CC)
Beyond the preview
Go deeper on NCT01735006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01735006.